SSX2 knockdown, in the 22Rv1 prostate cancer line, demonstrated a large fold change in many different EMT associated genes (TWIST1, ZEB2, MMP2, VIM, CDH1, CDH2) however these genes did not respond in an anticipated or canonical way (Figure 2E). Here, MMP2 is linked to prostate carcinoma.